| Ytd | 23.26% | |
| 1y | 40.39% |
| Open | 36.97 | Prev Close | 37.06 | Low | 36.65 | High | 37.44 | Mkt Cap | 2.35B |
| Vol | 298.95K | Avg Vol | 393.99K | EPS | 1.04 | P/E | 35.66 | Forward P/E | 25.95 |
| Beta | 0.10 | Short Ratio | 8.81 | Inst. Own | 60.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 39.95 | 200-d Avg | 35.55 | 1yr Est | 48.83 |
Bank of America Corp DE increased its position in shares of Guardian Pharmacy Services, Inc. (NYSE:
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will
Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the
Guardian Pharmacy Service (NYSE:GRDN) raises FY2026 sales outlook from $1.400 billion-$1.420 billion
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading
First Trust Advisors LP bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE: GRDN
Arrowstreet Capital Limited Partnership increased its stake in Guardian Pharmacy Services, Inc. (NYS
Bessemer Group Inc. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE: GRDN) during th
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will
Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation’s largest and most innovative long-t
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concep
Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The lat
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
B of A Securities analyst Allen Lutz maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy a
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future?
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 202
Guardian Pharmacy Services NYSE: GRDN reported what executives described as a solid first quarter of
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Z
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earni
Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrade
B of A Securities analyst Allen Lutz initiates coverage on Guardian Pharmacy Service (NYSE:GRDN)
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
Jefferies analyst Brian Tanquilut initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) wit
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and the headline were update
Stock futures slightly lower, Alibaba falls after downbeat earnings, other stocks decline in pre-mar
Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its
Five Below Inc (FIVE) shares rose 7.2% in pre-market trading after reporting better-than-expected Q4
US stock futures mixed on Thursday, with focus on Accenture, Micron, Alibaba's earnings. Guardia
The Offering for GRDN's Class A common stock, consisting of 3,980,000 shares being offered by ce
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Out
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a
Guardian Pharmacy Service (NYSE:GRDN) affirms FY2026 sales outlook from $1.400 billion-$1.420 billio
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.33 per share which beat the
Stephens & Co. analyst Scott Fidel maintains Guardian Pharmacy Service (NYSE:GRDN) with a Ov
Guardian Pharmacy Services (NYSE:GRDN), one of the nation's leading long-term care ("LTC"